Dysplasia of cervix
Therapeutic area
Reproductive Health
Rare disease
No
- Definition
- Abnormal development of immature squamous epithelial cells of the uterine cervix, a term used to describe premalignant cytological changes in the cervical epithelium. These atypical cells do not penetrate the epithelial basement membrane.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Dysplasia of cervix
- Alternative names
- dysplasia of cervix
- Therapeutic area
- Reproductive Health
- All therapeutic areas
- Reproductive Health
Sources for recorded values
- Severity
- Mild
- MONDO ID
- MONDO:0006736
- Parent condition
- MONDO:0005039
Related records
Broader conditions (4)
- Disease
- Disease by body system or component
- Human disease
- Reproductive system disorder
Narrower conditions (3)
- Cervical intraepithelial neoplasia
- Cervical intraepithelial neoplasia grade 2/3
- Cervical squamous intraepithelial neoplasia
Trials (416)
- A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
- A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
- A Comparison of Immediate Treatment of CIN1 With Cryotherapy and 12 Month Cytology Follow up in HIV Seropositive Women
- A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening
- A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.
- A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization
- A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
- A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening
- A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings
- A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
- A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
- A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
- A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
- A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
- A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia
- A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects
- A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients
- A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ
- A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
Drugs in development (14)
- Arundine Phase 3
- Cidofovir Phase 2
- Curcumin Phase 1
- Fluorouracil Phase 3
- Hexaminolevulinate Phase 2
- Imiquimod Phase 3
- Isotretinoin Phase 3
- Lidocaine Phase 3
- Methyl aminolevulinate Phase 1
- Nelfinavir Phase 2
- Progesterone Phase 2
- Sivifene Phase 2
- Sodium bicarbonate Phase 2
- Verpasep caltespen Phase 2